Michael S. Weiss

TG Therapeutics

Chief Executive Officer and President

Overview

Michael S. Weiss received an average compensation of $8,250,210 at TG Therapeutics from 2011 to 2017.

Annual data

2017

Non-Equity Incentive Plan$217,969
Salary$525,000
Stock Awards$9,183,647
Total$9,926,616

In 2017, Michael S. Weiss earned a total compensation of $9,926,616 as Chief Executive Officer and President at TG Therapeutics.

Weiss received $9,183,647 in stock awards, which accounts for 92.52% of total compensation.

Weiss also received $217,969 in non-equity incentive plan and $525,000 in salary.

2016

Non-Equity Incentive Plan$276,000
Salary$375,000
Stock Awards$3,225,935
Total$3,876,935

In 2016, Michael S. Weiss earned a total compensation of $3,876,935 as Chief Executive Officer and President at TG Therapeutics.

Weiss received $3,225,935 in stock awards, which accounts for 83.21% of total compensation.

Weiss also received $276,000 in non-equity incentive plan and $375,000 in salary.

2015

Non-Equity Incentive Plan$203,125
Salary$325,000
Stock Awards$13,440,772
Total$13,968,897

In 2015, Michael S. Weiss earned a total compensation of $13,968,897 as Chief Executive Officer and President at TG Therapeutics.

Weiss received $13,440,772 in stock awards, which accounts for 96.22% of total compensation.

Weiss also received $203,125 in non-equity incentive plan and $325,000 in salary.

2012

Salary$225,000
Stock Awards$11,003,601
Total$11,228,601

In 2012, Michael S. Weiss earned a total compensation of $11,228,601 as Executive Chairman, Interim Chief Executive Officer and President at TG Therapeutics.

Weiss received $11,003,601 in stock awards, which accounts for 98.00% of total compensation.

Weiss also received $225,000 in salary.

2011

Stock Awards$2,250,000
Total$2,250,000

In 2011, Michael S. Weiss earned a total compensation of $2,250,000 as Executive Chairman, Interim Chief Executive Officer and President at TG Therapeutics.

Weiss received $2,250,000 in stock awards, which accounts for 100.00% of total compensation.

Fortress Biotech

Executive Vice Chairman, Strategic Development

Overview

Michael S. Weiss received an average compensation of $5,277,307 at Fortress Biotech from 2014 to 2016.

Annual data

2016

Non-Equity Incentive Plan$500,000
Salary$29,689
Stock Awards$1,492,285
Other$72,015
Total$2,093,989

In 2016, Michael S. Weiss earned a total compensation of $2,093,989 as Executive Vice Chairman, Strategic Development at Fortress Biotech.

Weiss received $1,492,285 in stock awards, which accounts for 71.27% of total compensation.

Weiss also received $500,000 in non-equity incentive plan, $29,689 in salary and $72,015 in other compensation.

2015

Non-Equity Incentive Plan$500,000
Salary$28,275
Stock Awards$1,424,111
Other$1,114,341
Total$3,066,727

In 2015, Michael S. Weiss earned a total compensation of $3,066,727 as Executive Vice Chairman, Strategic Development at Fortress Biotech.

Weiss received $1,424,111 in stock awards, which accounts for 46.44% of total compensation.

Weiss also received $500,000 in non-equity incentive plan, $28,275 in salary and $1,114,341 in other compensation.

2014

Salary$24,324
Stock Awards$10,646,881
Total$10,671,205

In 2014, Michael S. Weiss earned a total compensation of $10,671,205 as Executive Vice Chairman, Strategic Development at Fortress Biotech.

Weiss received $10,646,881 in stock awards, which accounts for 99.77% of total compensation.

Weiss also received $24,324 in salary.

Keryx Biopharmaceuticals

Former Chairman and Chief Executive Officer

Overview

Michael S. Weiss received an average compensation of $4,302,891 at Keryx Biopharmaceuticals from 2006 to 2009.

Annual data

2009

Option Awards$263,585
Salary$273,085
Stock Awards$396,000
Other$666,705
Total$1,599,375

In 2009, Michael S. Weiss earned a total compensation of $1,599,375 as Former Chairman and Chief Executive Officer at Keryx Biopharmaceuticals.

Weiss received $666,705 in other compensation, which accounts for 41.69% of total compensation.

Weiss also received $263,585 in option awards, $273,085 in salary and $396,000 in stock awards.

2008

Non-Equity Incentive Plan$368,900
Salary$434,000
Stock Awards$378,000
Total$1,180,900

In 2008, Michael S. Weiss earned a total compensation of $1,180,900 as Former Chairman and Chief Executive Officer at Keryx Biopharmaceuticals.

Weiss received $434,000 in salary, which accounts for 36.75% of total compensation.

Weiss also received $368,900 in non-equity incentive plan and $378,000 in stock awards.

2007

Non-Equity Incentive Plan$206,310
Option Awards$5,061,674
Salary$390,000
Total$5,657,984

In 2007, Michael S. Weiss earned a total compensation of $5,657,984 as Chairman and Chief Executive Officer at Keryx Biopharmaceuticals.

Weiss received $5,061,674 in option awards, which accounts for 89.46% of total compensation.

Weiss also received $206,310 in non-equity incentive plan and $390,000 in salary.

2006

Non-Equity Incentive Plan$2,292,500
Option Awards$6,100,980
Salary$375,000
Other$4,824
Total$8,773,304

In 2006, Michael S. Weiss earned a total compensation of $8,773,304 as Chairman and Chief Executive Officer at Keryx Biopharmaceuticals.

Weiss received $6,100,980 in option awards, which accounts for 69.54% of total compensation.

Weiss also received $2,292,500 in non-equity incentive plan, $375,000 in salary and $4,824 in other compensation.